| 发布于: | iPhone | 转发：0 | 回复：1 | 喜欢：0 |
$康宁杰瑞制药-B(09966)$ 继续实验 TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform (PDP) to advance its pipeline of novel targeted cancer therapeutics and to partner with ...
不是的。IDMC 审核了73人，确认4人应答，而研究者认为是9人。以谁为准？还剩9人刚入组，还需2-3个月。这9人要有5人应答，多难。所以跌40%+。